These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24445091)

  • 1. Is there a need for MRI within 24 hours after CT-guided percutaneous thermoablation of the liver?
    Ringe KI; Wacker F; Raatschen HJ
    Acta Radiol; 2015 Jan; 56(1):10-7. PubMed ID: 24445091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
    Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
    Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma.
    Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Okamoto K; Murawaki Y; Kakite S
    Eur J Radiol; 2012 Oct; 81(10):2730-6. PubMed ID: 22137612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of computed tomography versus magnetic resonance imaging in assessing radiofrequency ablation margins after radiofrequency ablation in patients with hepatocellular carcinomas.
    Qu JR; Liu CC; Zhang HK; Li X; Zhang JW; Luo JP; Shao NN; Zhang SN; Li YL; Li HL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):480-5. PubMed ID: 23134824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases.
    Schraml C; Clasen S; Schwenzer NF; Koenigsrainer I; Herberts T; Claussen CD; Pereira PL
    Abdom Imaging; 2008; 33(6):643-51. PubMed ID: 18175165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
    Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
    J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.
    Elias D; De Baere T; Smayra T; Ouellet JF; Roche A; Lasser P
    Br J Surg; 2002 Jun; 89(6):752-6. PubMed ID: 12027986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous imaging-guided cryoablation of liver tumors: predicting local progression on 24-hour MRI.
    Shyn PB; Mauri G; Alencar RO; Tatli S; Shah SH; Morrison PR; Catalano PJ; Silverman SG
    AJR Am J Roentgenol; 2014 Aug; 203(2):W181-91. PubMed ID: 24555531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative magnetic resonance imaging ablation of hepatic tumors.
    Martin RC
    Am J Surg; 2005 Apr; 189(4):388-94. PubMed ID: 15820448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
    Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ
    J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI assessment of percutaneous ablation of liver tumors: value of subtraction images.
    Tatli S; Acar M; Tuncali K; Sadow CA; Morrison PR; Silverman SG
    J Magn Reson Imaging; 2013 Feb; 37(2):407-13. PubMed ID: 23023832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
    Dill-Macky MJ; Asch M; Burns P; Wilson S
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S287-95. PubMed ID: 16632690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic radiofrequency under CT-fluoroscopy guidance.
    Laganà D; Carrafiello G; Mangini M; Lumia D; Mocciardini L; Chini C; Pinotti G; Cuffari S; Fugazzola C
    Radiol Med; 2008 Feb; 113(1):87-100. PubMed ID: 18338130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility, efficacy, and safety of percutaneous MR-guided ablation of small (≤12 mm) hepatic malignancies.
    Weiss J; Hoffmann R; Rempp H; Keβler DE; Pereira PL; Nikolaou K; Clasen S
    J Magn Reson Imaging; 2019 Feb; 49(2):374-381. PubMed ID: 30221797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
    Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
    Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies.
    Frieser M; Kiesel J; Lindner A; Bernatik T; Haensler JM; Janka R; Hahn EG; Strobel D
    Ultraschall Med; 2011 Apr; 32(2):148-53. PubMed ID: 21225567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
    Lu DS; Yu NC; Raman SS; Limanond P; Lassman C; Murray K; Tong MJ; Amado RG; Busuttil RW
    Radiology; 2005 Mar; 234(3):954-60. PubMed ID: 15681691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI and CT characteristics of successfully ablated renal masses: Imaging surveillance after radiofrequency ablation.
    Davenport MS; Caoili EM; Cohan RH; Ellis JH; Higgins EJ; Willatt J; Fox GA
    AJR Am J Roentgenol; 2009 Jun; 192(6):1571-8. PubMed ID: 19457820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.